Glyconanoparticle Action Mechanism Study Service
Overview
Glyconanoparticles are nanoscale particles decorated with carbohydrates that interest biomedical and other research due to their unique properties and potential applications including drug delivery, diagnostics, and therapeutics. Understanding their mechanism of action is critical to optimize design and improve functionality. CD BioGlyco offers a glyconanoparticle action mechanism research service and is committed to providing the most expert guidance and research insights for various projects. This service is available for all types of glyconanoparticles, including but not limited to Carbohydrate-based Nanoparticles, Gold Glyconanoparticles, Silver Glyconanoparticles, Magnetic Glyconanoparticles, etc.
Unlocking the Secrets of Glyconanoparticles Through Action Mechanism Research
We provide an in-depth understanding of glyconanoparticle interactions with biological systems and explore their binding affinity, cell uptake, and bioactivity for various basic research. Specific services include the following:
Glyconanoparticle Development
Glyconanoparticles are widely used due to their excellent targeting and slow-release properties. Leveraging our extensive research experience and the robust GlycoNano™ Platform, we employ advanced computational models to accurately predict the structure and properties of glyconanoparticles, enabling us to design optimal formulations. To cater to various application requirements, we meticulously prepare glyconanoparticles using a range of high-performance carbohydrates and synthetic polymers. By fine-tuning the preparation process, including adjusting monomer concentration, reaction time, temperature, and other conditions, we obtain glyconanoparticles with ideal particle size, morphology, and stability. A stringent quality control system ensures that all prepared glyconanoparticles meet our high expectations.
Glyconanoparticle Characterization
We use state-of-the-art technology to perform comprehensive characterization and in-depth analysis of glyconanoparticles. Specific characterization includes Physicochemical Properties such as particle size and distribution, structure and morphology, zeta potential, and Interaction Analysis with proteins, lipids, etc.
- Particle size and morphology analysis
The particle size, shape, and size of glyconanoparticles are analyzed using techniques such as transmission electron microscopy (TEM), dynamic light scattering (DLS), and other technologies. These parameters are important for understanding the physicochemical properties of glyconanoparticles and their behavior in organisms. - Structural analysis
The chemical composition of the glyconanoparticles is analyzed in detail to reveal the functional groups on the surface of the glyconanoparticle and the types of chemical bonds that may be present. - Interaction analysis
The binding affinity of glyconanoparticles is analyzed using DLS and other methods, and their interactions with other active molecules are analyzed in detail to better study the mechanism of action of glyconanoparticles.
Glyconanoparticle Action Mechanism Study and Other Preclinical Study
We have abundant In Vivo and In Vitro Models to analyze the stability, functionality, and mechanism of action of glyconanoparticles in detail, including the following:
- We evaluate the physical, chemical, and storage Stability of glyconanoparticles under different environmental conditions (e.g., pH, temperature, light, etc.). This is essential to ensure the stability and effectiveness of glyconanoparticles in organisms.
- Different cell lines (e.g. cancer cells, primary cell lines) are utilized to study the cellular uptake mechanisms and to assess the specific interactions and targeting of glyconanoparticles with receptors. We also assess the cytotoxicity and biocompatibility of glyconanoparticles by MTT assay, flow cytometry, etc.
- The targeting, Pharmacokinetics, Pharmacodynamics, biodistribution, and biological functions (e.g., drug-carrying capacity and release characteristics) of glyconanoparticles are evaluated using different animal models. The effects of glyconanoparticles on cell signaling pathways are also investigated through cellular experiments and molecular biology techniques (e.g., gene expression analysis, protein blotting, etc.), and their mechanisms of action and biological effects in organisms are comprehensively analyzed.
Workflow
The glyconanoparticle action mechanism research services include initial project consultation, glyconanoparticle design, preparation, characterization, and detailed action mechanism studies. Our team of experts will be the first to communicate with you to understand your research objectives and experimental requirements in detail. After that, we accurately predict and prepare the glyconanoparticle that meets the expectation. After a detailed structure and action mechanism study, we complete a detailed experimental analysis report and provide continuous follow-up research support.

Applications
- Glyconanoparticle action mechanism studies provide valuable information for the development of glyconanoparticle-based biosensors and disease-related imaging agents.
- Glyconanoparticle action mechanism studies provide valuable information for the development of glyconanoparticle-based drug delivery systems with improved therapeutic efficacy.
- Glyconanoparticle action mechanism studies play an important role in the development of glyconanoparticle-based delivery systems for cosmeceuticals and skin care products.
Advantages
- We have detailed insights and conduct multifaceted glyconanoparticle action mechanism research.
- We follow a strict quality control system and glyconanoparticle action mechanism research is faster and results are more accurate.
- As experts in the glyconanoparticle field, our glyconanoparticle action mechanism research services provide extensive support for vaccine development, targeted cancer therapy research, and more.
Publication Data
Technology: Automated glycan assembly (AGA), DLS, TEM, AFM
Journal: ACS Applied Bio Materials
IF: 4.7
Published: 2022
Results: In this study, an ultra-small glyconanoparticle modified with non-immunogenic α-(1-6)-oligomannans was prepared. Analysis of the immunomodulatory effects of this nanoparticle showed that it was stable in water and triggered innate immune responses without affecting the complement system. It promotes the analysis of pro-inflammatory cytokines by crossing the NF-κB signaling pathway, which can be used as an immunomodulator and has good applications in combination therapy. The present study provides theoretical support for the development of glyconanoparticles that can modulate immune responses and be used in anticancer therapy.
Fig.1 Development and functional study of ultrasmall glyconanoparticles. (Ghosh, et al., 2022)
Frequently Asked Questions
- What research areas are our glyconanoparticle action mechanism research service applicable to?
This service is available to researchers, pharmaceutical companies, and academic institutions interested in nanotechnology, targeted drug delivery systems, immunotherapy, or other areas of glycobiology. - How do we study the action mechanism of glyconanoparticles?
We combine several advanced techniques to study the glyconanoparticle action mechanism, including but not limited to the following:- AFM
- Scanning electron microscope (SEM)
- DLS
- Surface plasmon resonance (SPR)
- TEM
- Nuclear magnetic resonance (NMR)
- Thermo gravimetric analyzer (TGA)
- Action mechanism studies based on different in vitro cellular models
- Action mechanism studies based on different animal models
At CD BioGlyco, with our advanced technology and expertise, we help understand and utilize the unique properties of glyconanoparticles through detailed glyconanoparticle action mechanism studies to develop a variety of innovative applications. Please feel free to contact us to learn how we support your R&D needs!
Reference
- Ghosh, C.; et al. Synthetic glyconanoparticles modulate innate immunity but not the complement system. ACS applied bio materials. 2022, 5(5): 2185-2192.
Quick Links
Resources
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform




